Copyright
©The Author(s) 2017.
World J Transplant. Feb 24, 2017; 7(1): 70-80
Published online Feb 24, 2017. doi: 10.5500/wjt.v7.i1.70
Published online Feb 24, 2017. doi: 10.5500/wjt.v7.i1.70
Center | ComparisonGroup with CLTx (number, diagnosis) | PGD (grade)PostOP-ECMO | ICU LOS (d) | Hospital LOS(d) | Survival 1 year | Survival 5 years |
Paris | No | Not reported | Not reported | Not reported | ddLLTx: 86% | Not reported |
Reina Sofia | Yes (149 - mixed)1 | Not reported | Not reported | Not reported | ddLLTx: 50%, CLTx: 72%1 | Not reported |
Hamburg | Yes (28 - mixed)4 | Not reported | Not reported | Not reported | ddLLTx: 85%, CLTx: 72%4 | Not reported |
Alfred | Yes (329 - mixed) | ddLLTx: 56% ≥ PGD (2) | LLT: 12; CLTx: 4 | ddLLTx: 30 CLTx: 21 | ddLLTx: 81%, CLTx: 84% (P = 0.115) | ddLLTx: 52%5, CLTx: 37.5%5 (P = 0.115) |
Zurich | Yes (219 - mixed) | ddLLTx: 13% PGD (not spec.) | Not reported | Not reported | ddLLTx: 82%; CLTx: 88% (P = 0.56) | ddLLTx: 64%; CLTx: 69% (P = 0.56) |
UPMC | Yes (691 - mixed)2, Yes (65 - high LAS)3 | ddLLTx: 36% ECMO | Not reported | Not reported | ddLLTx: 76%; CLTx: 83%1; (high LAS): 72%2 | Not reported |
Foch | Yes (445 - mixed) | ddLLTx: 54% ≥ PGD (1) 20% ECMO | ddLLTx: 17 | ddLLTx: 43 | ddLLTx: 60%, CLTx: 78% (NS) | ddLLTx: 46%, CLTx: 51% (NS) |
Vienna | Yes (778 - mixed) | ddLLTx: 44% ≥ PGD1 32% ECMO | ddLLTx: 17; CLTx: 6 | ddLLTx: 33.5 CLTx: 22 | ddLLTx: 65.1; CLTx: 84.8% (P < 0.001) | ddLLTx: 54.9% CLTx: 69.9% (P < 0.001) |
Leuven | Yes (66 - all CF) | ddLLTx: 25% PGD (3) at 48 h vs CLTx: 9% | ddLLTx: 12 CLTx: 5 | ddLLTx: 37 CLTx: 24 | ddLLTx: 100%; CLTx: 88.4% (NS) | Not reported |
- Citation: Eberlein M, Reed RM, Chahla M, Bolukbas S, Blevins A, Van Raemdonck D, Stanzi A, Inci I, Marasco S, Shigemura N, Aigner C, Deuse T. Lobar lung transplantation from deceased donors: A systematic review. World J Transplant 2017; 7(1): 70-80
- URL: https://www.wjgnet.com/2220-3230/full/v7/i1/70.htm
- DOI: https://dx.doi.org/10.5500/wjt.v7.i1.70